Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06136650

MK-5684-004: A Randomized Study Comparing Opevesostat Plus Hormone Replacement Therapy to Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer After Prior Hormonal Therapy

Led by Merck Sharp & Dohme LLC · Updated on 2026-06-03

1314

Participants Needed

327

Research Sites

133 weeks

Total Duration

On this page

Sponsors

M

Merck Sharp & Dohme LLC

Lead Sponsor

O

Orion Corporation, Orion Pharma

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness and safety of opevesostat combined with hormone replacement therapy (HRT) compared to alternative treatments, abiraterone acetate or enzalutamide, in adults with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with one next-generation hormonal agent (NHA). The study aims to determine if opevesostat improves the time participants live without their cancer worsening on scans, considering both those with and without certain androgen receptor mutations. Overall survival was also added as a secondary outcome to be assessed over a longer period. Participants are randomly assigned to one of two treatment groups. One group receives oral opevesostat twice daily along with daily dexamethasone and fludrocortisone acetate, continuing until their disease progresses. Hydrocortisone is available as a rescue medication if needed. The other group receives either abiraterone acetate plus prednisone or enzalutamide daily, also until disease progression. The study is open-label, meaning both researchers and participants know which treatment is given. During the study, participants will have regular assessments including imaging scans to monitor cancer progression, blood tests, and questionnaires evaluating quality of life and symptoms. Researchers will track the time until cancer worsens on imaging, overall survival, response rates, pain progression, and side effects. These evaluations may continue for up to approximately 82 months. Safety monitoring and treatment adherence will be followed throughout the study period.

CONDITIONS

Brief Title

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirmed adenocarcinoma of the prostate without small cell histology
  • Prostate cancer progression within 6 months before screening while on androgen deprivation therapy or post bilateral orchiectomy
  • Evidence of distant metastatic disease shown by bone scan or CT/MRI
  • Disease progressed during or after treatment with one next-generation hormonal agent for hormone-sensitive or castration-resistant prostate cancer, with minimum treatment durations
  • Prior treatment with poly (ADP-ribose) polymerase inhibitor (PARPi) or deemed ineligible/refused PARPi
  • Ongoing androgen deprivation therapy with serum testosterone below 50 ng/dL
  • Eastern Clinical Oncology Group (ECOG) performance status of 0 or 1 within 10 days before randomization
  • Adequate organ function
  • Provided tumor tissue from fresh biopsy not previously irradiated
  • Hepatitis B surface antigen positive patients eligible if on antiviral therapy with undetectable viral load
  • Hepatitis C patients eligible if viral load undetectable at screening
  • Recovered to Grade 1 or baseline from prior adverse events, with exceptions for certain endocrine-related or neuropathy/osteopenia conditions
  • Well-controlled HIV infection on antiretroviral therapy
Not Eligible

You will not qualify if you...

  • Presence of gastrointestinal condition
  • Unable to swallow capsules or tablets
  • History of pituitary dysfunction
  • Poorly controlled diabetes mellitus
  • Abnormal serum potassium or sodium levels
  • Hypotension or uncontrolled hypertension despite therapy
  • Active or unstable cardio/cerebrovascular disease including thromboembolic events
  • History or family history of long QTc syndrome
  • Recent seizures or conditions predisposing to seizures
  • Clinically significant ventricular arrhythmias or heart block without pacemaker
  • Prior taxane-based chemotherapy for metastatic castration-resistant prostate cancer
  • Incomplete recovery from major surgery or ongoing surgical complications
  • Current treatment with CYP450-inducing antiepileptic drugs
  • Unstable thyroid hormone therapy within 6 months before study
  • Recent radiotherapy or radiation-related toxicities needing corticosteroids
  • Recent systemic anticancer therapy including investigational agents
  • Recent use of strong CYP3A4 inducers or P-glycoprotein inhibitors
  • Recent targeted small molecule or NHA therapy
  • Recent live or live-attenuated vaccination
  • Recent investigational agent or device use
  • Known hypersensitivity to study drugs or excipients
  • "Superscan" bone scan preventing evaluation of metastases
  • Active progressing additional malignancy needing treatment within 3 years
  • Diagnosis of immunodeficiency or recent high-dose immunosuppressive therapy
  • Known active central nervous system metastases or carcinomatous meningitis, with exceptions for stable treated brain metastases
  • Active autoimmune disease requiring systemic treatment in past 2 years
  • Active infection requiring systemic therapy
  • Concurrent active Hepatitis B and C infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to approximately 52 months or until disease progression

Participants receive assigned oral hormonal therapies continuously until disease progression. Those in the experimental group take opevesostat plus hormone replacement therapy daily, while those in the comparator group receive abiraterone plus prednisone or enzalutamide daily.

Regular visits as per protocol for treatment and assessments

Follow-up

Duration - Up to approximately 82 months

Participants are monitored for long-term outcomes including overall survival, response rates, and safety after treatment ends.

Visits according to follow-up schedule until study completion

Trial Site Locations

Total: 327 locations

1

The University of Arizona Cancer Center - North Campus ( Site 0073)

Tucson, Arizona, United States, 85719

Actively Recruiting

2

UCLA Hematology/Oncology - Santa Monica ( Site 0044)

Los Angeles, California, United States, 90404

Actively Recruiting

3

University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040)

Orange, California, United States, 92868

Actively Recruiting

4

University of California, Irvine (UCI) Health - UC Irvine Medical Center (0120)

Orange, California, United States, 92868

Actively Recruiting

5

Stanford Cancer Center ( Site 0036)

Palo Alto, California, United States, 94304

Actively Recruiting

6

Emad Ibrahim,MD,INC. ( Site 0012)

Redlands, California, United States, 92373

Completed

7

Kaiser Permanente Riverside Medical Center ( Site 0099)

Riverside, California, United States, 92505

Actively Recruiting

8

University of California Davis (UC Davis) Comprehensive Cancer Center ( Site 0114)

Sacramento, California, United States, 95817

Actively Recruiting

9

San Francisco VA Health Care System ( Site 0093)

San Francisco, California, United States, 94121

Actively Recruiting

10

Kaiser Permanente-Kaiser Permanente, Vallejo Medical Center, Adult Oncology ( Site 0101)

Vallejo, California, United States, 94589

Actively Recruiting

11

University of Colorado Anschutz Medical Campus ( Site 0046)

Aurora, Colorado, United States, 80045

Actively Recruiting

12

UCHealth Highlands Ranch Hospital ( Site 0111)

Highlands Ranch, Colorado, United States, 80129

Actively Recruiting

13

Colorado Clinical Research ( Site 0067)

Lakewood, Colorado, United States, 80228

Actively Recruiting

14

University of Colorado Health - Lone Tree Medical Center ( Site 0112)

Lone Tree, Colorado, United States, 80124

Actively Recruiting

15

Yale-New Haven Hospital-Yale Cancer Center ( Site 0064)

New Haven, Connecticut, United States, 06510

Actively Recruiting

16

MedStar Washington Hospital Center ( Site 0103)

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

17

Florida Cancer Specialists - South ( Site 7003)

Fort Myers, Florida, United States, 33901

Active, Not Recruiting

18

Mount Sinai Cancer Center ( Site 0107)

Miami Beach, Florida, United States, 33140

Actively Recruiting

19

Memorial Hospital West-Memorial Cancer Institute ( Site 0109)

Pembroke Pines, Florida, United States, 33028

Actively Recruiting

20

Northside Hospital-Northside Hospital Oncology Network ( Site 0100)

Atlanta, Georgia, United States, 30342

Actively Recruiting

21

Edward-Elmhurst Healthcare, Elmhurst Hospital-Nancy W. Knowles Cancer Center ( Site 0074)

Elmhurst, Illinois, United States, 60126

Actively Recruiting

22

Edward-Elmhurst Healthcare, Edward Hospital-Edward Cancer Center ( Site 0075)

Naperville, Illinois, United States, 60540

Actively Recruiting

23

Illinois Cancer Care ( Site 0104)

Peoria, Illinois, United States, 61615

Actively Recruiting

24

Urology of Indiana - Carmel ( Site 0055)

Carmel, Indiana, United States, 46032

Actively Recruiting

25

University of Kentucky Chandler Medical Center ( Site 0048)

Lexington, Kentucky, United States, 40536

Active, Not Recruiting

26

Baltimore Veterans Affairs Medical Center ( Site 0069)

Baltimore, Maryland, United States, 21201

Actively Recruiting

27

Greenebaum Comprehensive Cancer Center ( Site 0049)

Baltimore, Maryland, United States, 21201

Actively Recruiting

28

Chesapeake Urology ( Site 0009)

Towson, Maryland, United States, 21204

Actively Recruiting

29

Henry Ford Hospital ( Site 0015)

Detroit, Michigan, United States, 48202

Actively Recruiting

30

Cancer and Hematology Centers of Western Michigan ( Site 0005)

Grand Rapids, Michigan, United States, 49503

Actively Recruiting

31

Avera Cancer Institute - Marshall (Site 0122)

Marshall, Minnesota, United States, 56258

Actively Recruiting

32

HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072)

Saint Louis Park, Minnesota, United States, 55426

Actively Recruiting

33

HealthPartners Cancer Research Center-HealthPartners Cancer Center at Regions Hospital ( Site 0092)

Saint Paul, Minnesota, United States, 55101

Actively Recruiting

34

St. Vincent Frontier Cancer Center-Research ( Site 0037)

Billings, Montana, United States, 59102

Actively Recruiting

35

Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026)

Omaha, Nebraska, United States, 68130

Actively Recruiting

36

OptumCare Cancer Care-Research Department ( Site 0078)

Las Vegas, Nevada, United States, 89102

Actively Recruiting

37

Comprehensive Cancer Centers of Nevada ( Site 0010)

Las Vegas, Nevada, United States, 89148

Actively Recruiting

38

Rutgers Cancer Institute of New Jersey ( Site 0033)

New Brunswick, New Jersey, United States, 08901

Actively Recruiting

39

Associated Medical Professionals - Urology ( Site 0081)

Syracuse, New York, United States, 13210

Actively Recruiting

40

University Hospitals Cleveland Medical Center ( Site 0043)

Cleveland, Ohio, United States, 44106

Actively Recruiting

41

Central Ohio Urology Group - Gahanna ( Site 0098)

Gahanna, Ohio, United States, 43230

Active, Not Recruiting

42

Genesis Healthcare System ( Site 0102)

Zanesville, Ohio, United States, 43701

Actively Recruiting

43

MidLantic urology ( Site 0022)

Bala-Cynwyd, Pennsylvania, United States, 19004

Actively Recruiting

44

Fox Chase Cancer Center ( Site 0076)

Philadelphia, Pennsylvania, United States, 19111

Actively Recruiting

45

Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083)

Charleston, South Carolina, United States, 29401

Actively Recruiting

46

Avera Cancer Institute - Aberdeen (Site 0123)

Aberdeen, South Dakota, United States, 57401

Actively Recruiting

47

Avera Cancer Institute - Mitchell (Site 0121)

Mitchell, South Dakota, United States, 57301

Actively Recruiting

48

Avera Cancer Institute - Pierre ( Site 0118)

Pierre, South Dakota, United States, 57501

Active, Not Recruiting

49

Avera Cancer Institute- Research ( Site 0094)

Sioux Falls, South Dakota, United States, 57105

Actively Recruiting

50

Avera Cancer Institute - Yankton ( Site 0117)

Yankton, South Dakota, United States, 57078

Actively Recruiting

51

The West Clinic, PLLC dba West Cancer Center ( Site 0063)

Germantown, Tennessee, United States, 38138

Actively Recruiting

52

Texas Oncology - Central/South Texas ( Site 8003)

Austin, Texas, United States, 78731

Actively Recruiting

53

Texas Oncology - DFW ( Site 8001)

Dallas, Texas, United States, 75246

Actively Recruiting

54

Texas Oncology - Gulf Coast ( Site 8002)

Houston, Texas, United States, 77024

Actively Recruiting

55

University of Virginia Health System ( Site 0054)

Charlottesville, Virginia, United States, 22908

Actively Recruiting

56

Inova Schar Cancer Institute ( Site 0017)

Fairfax, Virginia, United States, 22031

Actively Recruiting

57

Virginia Cancer Specialists (VCS) ( Site 8004)

Fairfax, Virginia, United States, 22031

Actively Recruiting

58

VCU Health Adult Outpatient Pavillion ( Site 0061)

Richmond, Virginia, United States, 23219

Actively Recruiting

59

Blue Ridge Cancer Care ( Site 0004)

Roanoke, Virginia, United States, 24014

Actively Recruiting

60

Spokane Urology ( Site 0035)

Spokane, Washington, United States, 99202

Actively Recruiting

61

Northwest Cancer Specialists (Compass Oncology) ( Site 8008)

Vancouver, Washington, United States, 98684

Actively Recruiting

62

MEDICAL COLLEGE OF WISCONSIN ( Site 0020)

Milwaukee, Wisconsin, United States, 53226

Actively Recruiting

63

Macquarie University-MQ Health Clinical Trials Unit ( Site 0214)

Macquarie University, New South Wales, Australia, 2109

Actively Recruiting

64

Westmead Hospital ( Site 0212)

Westmead, New South Wales, Australia, 2145

Actively Recruiting

65

Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Site 0211)

Brisbane, Queensland, Australia, 4029

Actively Recruiting

66

Monash Health ( Site 0219)

Clayton, Victoria, Australia, 3168

Actively Recruiting

67

Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0210)

Melbourne, Victoria, Australia, 3000

Actively Recruiting

68

CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA ( Site 0256)

Fortaleza, Ceará, Brazil, 60336-232

Active, Not Recruiting

69

Hospital Santa Rita de Cassia ( Site 0271)

Vitória, Espírito Santo, Brazil, 29043-260

Actively Recruiting

70

Obras Sociais Irma Dulce ( Site 0255)

Salvador, Estado de Bahia, Brazil, 40415-006

Active, Not Recruiting

71

Hospital São Domingos ( Site 0258)

São Luís, Maranhão, Brazil, 65060-645

Active, Not Recruiting

72

Hospital Mario Penna ( Site 0264)

Belo Horizonte, Minas Gerais, Brazil, 30380-472

Active, Not Recruiting

73

Universidade Federal do Triangulo Mineiro - Hospital de Clinicas ( Site 0262)

Uberaba, Minas Gerais, Brazil, 38025-350

Actively Recruiting

74

ICTRIALS Pesquisa e Desenvolvimento ( Site 0274)

Curitiba, Paraná, Brazil, 80510-130

Actively Recruiting

75

Hospital Universitário Evangélico Mackenzie ( Site 0252)

Curitiba, Paraná, Brazil, 80730-150

Actively Recruiting

76

Hospital São Lucas da PUCRS ( Site 0270)

Porto Alegre, Rio Grande do Sul, Brazil, 90610-000

Actively Recruiting

77

Clínica de Neoplasias Litoral ( Site 0269)

Itajaí, Santa Catarina, Brazil, 88301-220

Actively Recruiting

78

Hospital Universitário São Francisco de Assis - Bragança Paulista ( Site 0251)

Bragança Paulista, São Paulo, Brazil, 12916-542

Actively Recruiting

79

Hospital de Base de São José do Rio Preto ( Site 0275)

São José do Rio Preto, São Paulo, Brazil, 15090-000

Actively Recruiting

80

Instituto do Câncer Brasil - Unidade Taubaté ( Site 0263)

Taubaté, São Paulo, Brazil, 12030-200

Active, Not Recruiting

81

Hospital Paulistano ( Site 0259)

São Paulo, Brazil, 01321-001

Active, Not Recruiting

82

Cross Cancer Institute (Site 0281)

Edmonton, Alberta, Canada, T6G 1Z2

Actively Recruiting

83

Trillium Health Partners - Credit Valley Hospital ( Site 0289)

Mississauga, Ontario, Canada, L5M 2N1

Actively Recruiting

84

The Ottawa Hospital - General Campus ( Site 0286)

Ottawa, Ontario, Canada, K1H 8L6

Actively Recruiting

85

Sunnybrook Research Institute ( Site 0285)

Toronto, Ontario, Canada, M4N 3M5

Actively Recruiting

86

Centre Hospitalier de l'Université de Montréal ( Site 0276)

Montreal, Quebec, Canada, H2X 3E4

Active, Not Recruiting

87

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0277)

Québec, Quebec, Canada, G1J 1Z4

Active, Not Recruiting

88

CIDO SpA-Oncology ( Site 0302)

Temuco, Araucania, Chile, 4810218

Actively Recruiting

89

Clinica Universidad Catolica del Maule-Oncology ( Site 0306)

Talca, Maule Region, Chile, 3465584

Actively Recruiting

90

FALP ( Site 0303)

Santiago, Region M. de Santiago, Chile, 7500921

Actively Recruiting

91

Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0304)

Santiago, Region M. de Santiago, Chile, 8330024

Actively Recruiting

92

Bradfordhill-Clinical Area ( Site 0301)

Santiago, Region M. de Santiago, Chile, 8420383

Actively Recruiting

93

ONCOCENTRO APYS-ACEREY ( Site 0305)

Viña del Mar, Valparaiso, Chile, 2520598

Actively Recruiting

94

The Second Hospital Of Anhui Medical University ( Site 1633)

Hefei, Anhui, China, 230000

Actively Recruiting

95

Peking University First Hospital-Urology ( Site 1602)

Beijing, Beijing Municipality, China, 100034

Actively Recruiting

96

Beijing Cancer hospital-Urinary Surgery ( Site 1620)

Beijing, Beijing Municipality, China, 100142

Actively Recruiting

97

First Medical Center of Chinese PLA General Hospital ( Site 1601)

Beijing, Beijing Municipality, China, 100853

Actively Recruiting

98

Beijing Cancer Hospital ( Site 1623)

Beijing, Beijing Municipality, China, 130021

Actively Recruiting

99

Chongqing University Cancer Hospital ( Site 1603)

Chongqing, Chongqing Municipality, China, 400030

Actively Recruiting

100

Southwest Hospital of Third Military Medical University ( Site 1645)

Chongqing, Chongqing Municipality, China, 400038

Active, Not Recruiting

101

The First Affiliated Hospital Of Fujian Medical University-Urology ( Site 1639)

Fuzhou, Fujian, China, 350005

Actively Recruiting

102

The first affiliated hospital of Guangzhou medical university ( Site 1637)

Guangzhou, Guangdong, China, 510030

Actively Recruiting

103

Sun Yat-sen University Cancer Center-Urology Surgery ( Site 1638)

Guangzhou, Guangdong, China, 510700

Actively Recruiting

104

Tongji Hospital Tongji Medical,Science & Technology ( Site 1632)

Wuhan, Hubei, China, 430000

Actively Recruiting

105

The Central Hospital of Wuhan ( Site 1635)

Wuhan, Hubei, China, 430014

Actively Recruiting

106

Hubei Cancer Hospital-Urinary surgery ( Site 1631)

Wuhan, Hubei, China, 430079

Actively Recruiting

107

Hunan Cancer Hospital ( Site 1630)

Changsha, Hunan, China, 410013

Actively Recruiting

108

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( Site 1615)

Nanjing, Jiangsu, China, 210008

Actively Recruiting

109

Nantong Tumor Hospital-Urology ( Site 1609)

Nantong, Jiangsu, China, 226361

Actively Recruiting

110

Wuxi People's Hospital ( Site 1612)

Wuxi, Jiangsu, China, 214023

Actively Recruiting

111

The Second Affiliated Hospital of Xi'an Jiaotong University-Oncology Department ( Site 1619)

Xi'an, Shaanxi, China, 710004

Actively Recruiting

112

The First Affiliated Hospital of Xi'an Jiaotong University-Oncology department ( Site 1618)

Xi'an, Shaanxi, China, 710061

Actively Recruiting

113

Yantai Yuhuangding Hospital ( Site 1622)

Yantai, Shandong, China, 264099

Actively Recruiting

114

Renji Hosp Shanghai Jiaotong U School of Med ( Site 1624)

Shanghai, Shanghai Municipality, China, 200001

Active, Not Recruiting

115

Huadong Hospital Affiliated to Fudan University-Urology ( Site 1613)

Shanghai, Shanghai Municipality, China, 200041

Actively Recruiting

116

West China Hospital, Sichuan University-Urology Surgery ( Site 1642)

Chengdu, Sichuan, China, 610041

Actively Recruiting

117

Nanchong Central Hospital-urology ( Site 1647)

Nanchong, Sichuan, China, 500643

Actively Recruiting

118

The Second Hospital of Tianjin Medical University ( Site 1616)

Tianjin, Tianjin Municipality, China, 300211

Actively Recruiting

119

Xinjiang Medical University Cancer Hospital - Urumqi-Urology ( Site 1644)

Ürümqi, Xinjiang, China, 830000

Actively Recruiting

120

Yunnan Province Cancer Hospital ( Site 1643)

Kunming, Yunnan, China, 650107

Actively Recruiting

121

Zhejiang Provincial People's Hospital-Urology ( Site 1641)

Hangzhou, Zhejiang, China, 310014

Actively Recruiting

122

The First Hospital of Jiaxing-urology ( Site 1605)

Jiaxing, Zhejiang, China, 314001

Actively Recruiting

123

Ningbo First Hospital-Urology ( Site 1608)

Ningbo, Zhejiang, China, 315010

Actively Recruiting

124

The First Affiliated Hospital of Wenzhou Medical University ( Site 1604)

Wenzhou, Zhejiang, China, 325015

Actively Recruiting

125

Los Cobos Medical Center ( Site 0336)

Bogotá, Bogota D.C., Colombia, 110121

Active, Not Recruiting

126

Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 0326)

Bogotá, Bogota D.C., Colombia, 111321

Actively Recruiting

127

Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0327)

Valledupar, Cesar Department, Colombia, 200001

Actively Recruiting

128

IMAT S.A.S ( Site 0329)

Montería, Departamento de Córdoba, Colombia, 230002

Actively Recruiting

129

Fundación Cardiovascular de Colombia ( Site 0328)

Piedecuesta, Santander Department, Colombia, 681017

Actively Recruiting

130

Fundación Valle del Lili ( Site 0330)

Cali, Valle del Cauca Department, Colombia, 760032

Actively Recruiting

131

Clínica Imbanaco S.A.S ( Site 0334)

Cali, Valle del Cauca Department, Colombia, 760042

Active, Not Recruiting

132

CIMCA-Hemato-Oncology ( Site 0380)

San José, Provincia de San José, Costa Rica, 10103

Actively Recruiting

133

Hospital Metropolitano - Sede Lindora-Metropolitano Research Institute Sede Lindora ( Site 0379)

Santa Ana, Provincia de San José, Costa Rica, 10903

Actively Recruiting

134

Onco Tech, S.A. ( Site 0376)

San José, Costa Rica, 10103

Actively Recruiting

135

Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0403)

Brno, Brno-mesto, Czechia, 656 53

Actively Recruiting

136

Krajská nemocnice Liberec-Department of Urology ( Site 0407)

Liberec, Liberec Region, Czechia, 460 01

Active, Not Recruiting

137

Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 0401)

Prague, Praha 5, Czechia, 150 06

Actively Recruiting

138

Fakultni Nemocnice u sv. Anny v Brne-Onkologicko-chirurgicke oddeleni ( Site 0404)

Brno, South Moravian, Czechia, 602 00

Actively Recruiting

139

Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0405)

Olomouc, Czechia, 77900

Actively Recruiting

140

Vseobecna fakultni nemocnice v Praze ( Site 0406)

Prague, Czechia, 12808

Actively Recruiting

141

East-Tallinn Central Hospital ( Site 1528)

Tallinn, Harju, Estonia, 11314

Active, Not Recruiting

142

North Estonia Medical Centre Foundation ( Site 1526)

Tallinn, Harju, Estonia, 13419

Actively Recruiting

143

Pärnu Haigla (Site 1550)

Pärnu, Pärnumaa, Estonia, 80010

Actively Recruiting

144

Tartu University Hospital-Radiotherapy and oncology ( Site 1527)

Tartu, Tartu, Estonia, 50406

Actively Recruiting

145

Institut de cancérologie Strasbourg Europe (ICANS) ( Site 0451)

Strasbourg, Alsace, France, 67200

Actively Recruiting

146

Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest ( Site 0461)

Bordeaux, Aquitaine, France, 33076

Actively Recruiting

147

CENTRE LEON BERARD ( Site 0459)

Lyon Cedex08, Auvergne-Rhône-Alpes, France, 69373

Actively Recruiting

148

CHU-BREST Cavale Blanche ( Site 0456)

Brest, Finistere, France, 29609

Active, Not Recruiting

149

Ramsay Santé - Clinical La Croix Du Sud ( Site 0460)

Quint-Fonsegrives, Haute-Garonne, France, 31130

Active, Not Recruiting

150

Centre Bourgogne ( Site 0464)

Lille, Hauts-de-France, France, 59000

Actively Recruiting

151

Hôpital Foch ( Site 0455)

Suresnes, Hauts-de-Seine, France, 92150

Active, Not Recruiting

152

Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 0454)

Clermont-Ferrand, Puy-de-Dome, France, 63003

Active, Not Recruiting

153

Gustave Roussy ( Site 0452)

Villejuif, Val-de-Marne, France, 94800

Active, Not Recruiting

154

Sainte Catherine Institut du Cancer Avignon Provence ( Site 0458)

Avignon, Vaucluse, France, 84000

Active, Not Recruiting

155

Groupe Hospitalier Paris Saint Joseph ( Site 0465)

Paris, France, 75014

Active, Not Recruiting

156

Universitaetsklinikum Freiburg-Klinik für Urologie ( Site 0506)

Freiburg im Breisgau, Baden-Wurttemberg, Germany, 79106

Actively Recruiting

157

Universitaetsklinikum Heidelberg ( Site 0531)

Heidelberg, Baden-Wurttemberg, Germany, 69120

Actively Recruiting

158

Studienpraxis Urologie ( Site 0529)

Nürtingen, Baden-Wurttemberg, Germany, 72622

Actively Recruiting

159

klinikum rechts der isar der technischen universität münchen-Urologische Klinik und Poliklinik ( Site 0521)

Munich, Bavaria, Germany, 81675

Active, Not Recruiting

160

Caritas-Krankenhaus St. Josef-Klinik fuer Urologie ( Site 0523)

Regensburg, Bavaria, Germany, 93053

Actively Recruiting

161

Universitätsklinikum Marburg-Comprehensive Cancer Center ( Site 0510)

Marburg, Hesse, Germany, 35043

Completed

162

Universitätsmedizin Göttingen - Georg-August-Universität-Klinik für Urologie ( Site 0527)

Göttingen, Lower Saxony, Germany, 37075

Actively Recruiting

163

Marien-Krankenhaus ( Site 0515)

Bergisch Gladbach, North Rhine-Westphalia, Germany, 51465

Actively Recruiting

164

Universitaetsklinikum Koeln ( Site 0518)

Cologne, North Rhine-Westphalia, Germany, 50937

Active, Not Recruiting

165

Urologicum Duisburg (Site 00538)

Duisburg, North Rhine-Westphalia, Germany, 47169

Actively Recruiting

166

Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Urologie ( Site 0528)

Dresden, Saxony, Germany, 01307

Completed

167

Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0504)

Berlin, Germany, 10117

Actively Recruiting

168

Vivantes Klinikum Am Urban ( Site 0512)

Berlin, Germany, 10967

Actively Recruiting

169

UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 0553)

Pátrai, Achaia, Greece, 26504

Active, Not Recruiting

170

Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 0551)

Athens, Attica, Greece, 115 28

Actively Recruiting

171

ATTIKON GENERAL UNIVERSITY HOSPITAL-2nd Dep. of Int. Medicine. Research Unit & Diabetes Center ( Site 0552)

Chaïdári, Attica, Greece, 124 62

Actively Recruiting

172

MEDI-K ( Site 0576)

Guatemala City, Guatemala, 01009

Actively Recruiting

173

CELAN,S.A ( Site 0579)

Guatemala City, Guatemala, 01010

Actively Recruiting

174

INTEGRA Cancer Institute-Oncology ( Site 0578)

Guatemala City, Guatemala, 01010

Actively Recruiting

175

Private Practice- Dr. Rixci Augusto Lenin Ramírez ( Site 0577)

Guatemala City, Guatemala, 01010

Actively Recruiting

176

Sanatorio Nuestra Senora del Pilar ( Site 0580)

Guatemala City, Guatemala, 01015

Actively Recruiting

177

Hong Kong Integrated Oncology Centre ( Site 0603)

Central, Hong Kong, 999077

Actively Recruiting

178

Queen Mary Hospital ( Site 0602)

Hong Kong, Hong Kong

Actively Recruiting

179

Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Okta-Klinikai Onkológiai és Sugárterápiás C ( Site 0630)

Miskolc, Borsod-Abauj Zemplen county, Hungary, 3526

Actively Recruiting

180

Nograd Varmegyei Szent Lazar Korhaz-Onkologia es Sugarterapias Osztaly ( Site 0636)

Salgótarján, Nógrád megye, Hungary, 3100

Actively Recruiting

181

Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 0631)

Budapest, Pest County, Hungary, 1122

Actively Recruiting

182

Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 0632)

Debrecen, Hungary, 4032

Actively Recruiting

183

St. Vincent's University Hospital ( Site 0652)

Dublin, Dublin, Ireland, D04 T6F4

Actively Recruiting

184

Tallaght University Hospital ( Site 0651)

Dublin, Ireland, D24 NR0A

Actively Recruiting

185

Emek Medical Center ( Site 0680)

Afula, Israel, 1834111

Actively Recruiting

186

Rambam Health Care Campus-Oncology Division ( Site 0676)

Haifa, Israel, 3109601

Actively Recruiting

187

Shaare Zedek Medical Center ( Site 0679)

Jerusalem, Israel, 9103102

Actively Recruiting

188

Hadassah Medical Center ( Site 0683)

Jerusalem, Israel, 9112001

Actively Recruiting

189

Meir Medical Center. ( Site 0682)

Kfar Saba, Israel, 4428164

Actively Recruiting

190

Rabin Medical Center ( Site 0678)

Petah Tikva, Israel, 4941492

Actively Recruiting

191

Sheba Medical Center ( Site 0677)

Ramat Gan, Israel, 5265601

Actively Recruiting

192

Sourasky Medical Center ( Site 0681)

Tel Aviv, Israel, 6423906

Actively Recruiting

193

IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 1454)

Meldola, Emilia-Romagna, Italy, 47014

Active, Not Recruiting

194

Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1452)

Milan, Lombardy, Italy, 20133

Actively Recruiting

195

Ospedale Cannizzaro ( Site 1455)

Catania, Italy, 95126

Actively Recruiting

196

Azienda Ospedaliero Universitaria Policlinico Riuniti di Foggia ( Site 1456)

Foggia, Italy, 71100

Actively Recruiting

197

Ospedale San Raffaele-Oncologia Medica ( Site 1451)

Milan, Italy, 20132

Actively Recruiting

198

Azienda Ospedaliera Santa Maria Terni ( Site 1458)

Terni, Italy, 05100

Actively Recruiting

199

Toho University Sakura Medical Center ( Site 0730)

Sakura, Chiba, Japan, 285-8741

Actively Recruiting

200

University of Fukui Hospital ( Site 0735)

Eiheiji-cho,Yoshida-gun, Fukui, Japan, 910-1193

Actively Recruiting

201

Hospital of the University of Occupational and Environmental Health, Japan ( Site 0746)

Kitakyushu, Fukuoka, Japan, 807-8556

Actively Recruiting

202

Sapporo Medical University Hospital ( Site 0726)

Sapporo, Hokkaido, Japan, 060-8543

Actively Recruiting

203

Hokkaido University Hospital ( Site 0756)

Sapporo, Hokkaido, Japan, 060-8648

Actively Recruiting

204

Kobe University Hospital ( Site 0741)

Kobe, Hyōgo, Japan, 650-0017

Actively Recruiting

205

Kanazawa Medical University Hospital ( Site 0734)

Mukai-awagasaki, Ishikawa-ken, Japan, 920-0265

Actively Recruiting

206

Kagawa University Hospital ( Site 0744)

Kita, Kagawa-ken, Japan, 761-0701

Actively Recruiting

207

Yokohama City University Medical Center ( Site 0733)

Yokohama, Kanagawa, Japan, 232-0024

Actively Recruiting

208

Mie University Hospital ( Site 0737)

Tsu, Mie-ken, Japan, 514-8507

Active, Not Recruiting

209

National Hospital Organization Nagasaki Medical Center ( Site 0748)

Ōmura, Nagasaki, Japan, 856-8562

Actively Recruiting

210

Nara Medical University Hospital ( Site 0742)

Kashihara, Nara, Japan, 634-8522

Actively Recruiting

211

Nanbu Tokushukai Hospital ( Site 0755)

Shimajiri, Okinawa, Japan, 901-0417

Active, Not Recruiting

212

Kansai Medical University Hospital ( Site 0739)

Hirakata, Osaka, Japan, 573-1191

Actively Recruiting

213

Bell Land General Hospital ( Site 0740)

Sakai, Osaka, Japan, 599-8247

Active, Not Recruiting

214

The University of Osaka Hospital ( Site 0738)

Suita, Osaka, Japan, 565-0871

Actively Recruiting

215

Saga-Ken Medical Centre Koseikan ( Site 0747)

Saga, Saga-ken, Japan, 840-8571

Actively Recruiting

216

Nihon University Itabashi Hospital ( Site 0732)

Itabashiku, Tokyo, Japan, 173-8610

Completed

217

The Jikei University Hospital ( Site 0731)

Minato, Tokyo, Japan, 105-8471

Actively Recruiting

218

Akita University Hospital ( Site 0728)

Akita, Japan, 010-8543

Actively Recruiting

219

Kyushu University Hospital ( Site 0745)

Fukuoka, Japan, 812-8582

Active, Not Recruiting

220

Fukushima Medical University Hospital ( Site 0758)

Fukushima, Japan, 960-1295

Actively Recruiting

221

Gifu University Hospital ( Site 0736)

Gifu, Japan, 501-1112

Actively Recruiting

222

Hiroshima University Hospital ( Site 0743)

Hiroshima, Japan, 734-8551

Active, Not Recruiting

223

Kagoshima University Hospital ( Site 0754)

Kagoshima, Japan, 890-8520

Active, Not Recruiting

224

National Hospital Organization Kumamoto Medical Center ( Site 0749)

Kumamoto, Japan, 860-0008

Actively Recruiting

225

Miyazaki Prefectural Miyazaki Hospital ( Site 0752)

Miyazaki, Japan, 880-8510

Actively Recruiting

226

University of Miyazaki Hospital ( Site 0751)

Miyazaki, Japan, 889-1692

Actively Recruiting

227

Nagano Municipal Hospital ( Site 0757)

Nagano, Japan, 381-8551

Actively Recruiting

228

National Hospital Organization Oita Medical Center ( Site 0750)

Ōita, Japan, 870-0263

Completed

229

Liepaja Regional Hospital ( Site 1553)

Liepāja, Latvia, LV3414

Active, Not Recruiting

230

Pauls Stradins Clinical Univeristy Hospital-Urological department ( Site 1551)

Riga, Latvia, LV-1002

Actively Recruiting

231

Hospital of Lithuanian University of Health Sciences Kauno klinikos ( Site 1576)

Kaunas, Kaunas County, Lithuania, 50161

Actively Recruiting

232

National Cancer Institute ( Site 1577)

Vilnius, Vilniaus Miestas, Lithuania, 08660

Actively Recruiting

233

Hospital Sultan Ismail ( Site 0905)

Johor Bahru, Johor, Malaysia, 81100

Actively Recruiting

234

University Malaya Medical Centre ( Site 0902)

Lembah Pantai, Kuala Lumpur, Malaysia, 59100

Actively Recruiting

235

National Cancer Institute ( Site 0904)

Putrajaya, Putrajaya, Malaysia, 62250

Completed

236

Sarawak General Hospital-Radiotherapy Unit ( Site 0901)

Kuching, Sarawak, Malaysia, 93586

Actively Recruiting

237

Hospital Kuala Lumpur-Radiotherapy and Oncology ( Site 0903)

Kuala Lumpur, Malaysia, 50586

Actively Recruiting

238

CIO - Centro de Inmuno-Oncología de Occidente ( Site 0928)

Guadalajara, Jalisco, Mexico, 44630

Active, Not Recruiting

239

Health Pharma Professional Research S.A. de C.V: ( Site 0929)

Mexico City, Mexico City, Mexico, 03100

Active, Not Recruiting

240

Higiea Oncologia ( Site 0938)

Mexico City, Mexico City, Mexico, 11810

Active, Not Recruiting

241

Quemex Medical and Research ( Site 0937)

Tlalpan, Mexico City, Mexico, 14308

Active, Not Recruiting

242

Filios Alta Medicina ( Site 0931)

Monterrey, Nuevo León, Mexico, 64460

Active, Not Recruiting

243

Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 0932)

Monterrey, Nuevo León, Mexico, 64460

Active, Not Recruiting

244

Eukarya Pharmasite S.C. ( Site 0939)

Monterrey, Nuevo León, Mexico, 64718

Active, Not Recruiting

245

Centro de Investigacion Clinica de Oaxaca ( Site 0934)

Oaxaca City, Oaxaca, Mexico, 68020

Active, Not Recruiting

246

Dunedin Hospital ( Site 1032)

Dunedin, Otago, New Zealand, 9016

Completed

247

Auckland City Hospital ( Site 1033)

Auckland, New Zealand, 1023

Actively Recruiting

248

Aliada-Oncologìa ( Site 1055)

Lima, Peru, 15036

Actively Recruiting

249

IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 1052)

Lima, Peru, 15036

Actively Recruiting

250

Oncosalud-Clinical Research ( Site 1057)

Lima, Peru, 15036

Actively Recruiting

251

INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 1054)

Lima, Peru, 15038

Active, Not Recruiting

252

Hospital de Cascais Doutor José de Almeida ( Site 1158)

Alcabideche, Lisbon District, Portugal, 2755-009

Actively Recruiting

253

Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 1156)

Vila Nova de Gaia, Porto District, Portugal, 4434-502

Actively Recruiting

254

Unidade Local de Saude de Braga - Hospital de Braga ( Site 1151)

Braga, Portugal, 4710-243

Actively Recruiting

255

Hospital CUF - Tejo ( Site 1157)

Lisbon, Portugal, 1350-352

Actively Recruiting

256

Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 1153)

Lisbon, Portugal, 1649-035

Actively Recruiting

257

Unidade Local de Saude de Santo António - Hospital Santo António ( Site 1152)

Porto, Portugal, 4099-001

Actively Recruiting

258

Advance Urology and Laparoscopic Center ( Site 1178)

Ponce, Puerto Rico, 00716

Completed

259

Ad-Vance Medical Research-Research ( Site 1177)

Ponce, Puerto Rico, 00717

Actively Recruiting

260

Pan American Center for Oncology Trials - Ciudadela ( Site 1176)

San Juan, Puerto Rico, 00909

Actively Recruiting

261

Spitalul Universitar de Urgență Elias ( Site 1504)

Bucharest, Bucharest, Romania, 011461

Actively Recruiting

262

Cardiomed SRL Cluj-Napoca ( Site 1503)

Cluj-Napoca, Cluj, Romania, 400015

Active, Not Recruiting

263

SC Radiotherapy Center Cluj SRL ( Site 1502)

Florești, Cluj, Romania, 407280

Active, Not Recruiting

264

Centrul de Oncologie "Sfântul Nectarie" ( Site 1501)

Craiova, Dolj, Romania, 200746

Active, Not Recruiting

265

Spitalul Clinic ''Prof Dr. Theodor Burghele" (Site 1505)

Bucharest, Romania, 050659

Actively Recruiting

266

National University Hospital ( Site 1201)

Singapore, Central Singapore, Singapore, 119074

Actively Recruiting

267

National Cancer Centre Singapore ( Site 1202)

Singapore, Central Singapore, Singapore, 168583

Actively Recruiting

268

Singapore General Hospital ( Site 1204)

Singapore, Central Singapore, Singapore, 169608

Actively Recruiting

269

Tan Tock Seng Hospital-Medical Oncology ( Site 1203)

Singapore, Central Singapore, Singapore, 308433

Actively Recruiting

270

UROEXAM ( Site 1479)

Nitra, Nitra Region, Slovakia, 949 01

Actively Recruiting

271

Privatna Urologicka Ambulancia ( Site 1478)

Trenčín, Trenčín Region, Slovakia, 911 01

Actively Recruiting

272

CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE-Clinical Trials Unit ( Site 1230)

Port Elizabeth, Eastern Cape, South Africa, 6055

Actively Recruiting

273

Wits Clinical Research ( Site 1234)

Johannesburg, Gauteng, South Africa, 2193

Actively Recruiting

274

Wilgers Oncology Centre ( Site 1232)

Pretoria, Gauteng, South Africa, 0040

Actively Recruiting

275

Curo Oncology. ( Site 1237)

Pretoria, Gauteng, South Africa, 0084

Actively Recruiting

276

LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 1236)

Pretoria, Gauteng, South Africa, 0181

Actively Recruiting

277

Cape Town Oncology Trials ( Site 1233)

Cape Town, Western Cape, South Africa, 7570

Completed

278

National Cancer Center-Center for Urologic Cancer ( Site 1254)

Goyang-si, Kyonggi-do, South Korea, 10408

Actively Recruiting

279

Seoul National University Bundang Hospital-Urology ( Site 1253)

Seongnam, Kyonggi-do, South Korea, 13620

Actively Recruiting

280

Kyungpook National University Chilgok Hospital-Urology ( Site 1252)

Buk-gu, Kyongsangbuk-do, South Korea, 41404

Actively Recruiting

281

Pusan National University Yangsan Hospital ( Site 1256)

Pusan, Kyongsangnam-do, South Korea, 50612

Actively Recruiting

282

Seoul National University Hospital-Urology ( Site 1251)

Seoul, South Korea, 03080

Actively Recruiting

283

The Catholic University of Korea. Seoul St. Mary s Hospital ( Site 1255)

Seoul, South Korea, 06591

Actively Recruiting

284

Hospital Universitari Parc Tauli-oncologia ( Site 1282)

Sabadell, Barcelona, Spain, 08208

Actively Recruiting

285

HOSPITAL CLÍNIC DE BARCELONA-ICHMO- Clinic Institut of Haematological and Oncological diseases ( Site 1284)

Barcelona, Catalonia, Spain, 08036

Actively Recruiting

286

Institut Català d'Oncologia (ICO) - Girona ( Site 1285)

Girona, Gerona, Spain, 17007

Actively Recruiting

287

Complexo Hospitalario Universitario A Coruna ( Site 1288)

A Coruña, La Coruna, Spain, 15006

Actively Recruiting

288

Hospital Insular de Gran Canaria-Oncology ( Site 1280)

Las Palmas de Gran Canaria, Las Palmas, Spain, 35016

Actively Recruiting

289

HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 1283)

Pozuelo de Alarcón, Madrid, Spain, 28223

Actively Recruiting

290

Hospital Universitario de Burgos-Oncología ( Site 1281)

Burgos, Spain, 09006

Actively Recruiting

291

Hospital Quirón Málaga ( Site 1286)

Málaga, Spain, 29004

Actively Recruiting

292

Karolinska Universitetssjukhuset Solna ( Site 1302)

Stockholm, Stockholm County, Sweden, 171 64

Actively Recruiting

293

Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 1301)

Uppsala, Uppsala County, Sweden, 751 85

Actively Recruiting

294

Chi Mei Medical Center ( Site 1336)

Tainan, Tainan, Taiwan, 71004

Actively Recruiting

295

Kaohsiung Veterans General Hospital ( Site 1337)

Kaohsiung City, Taiwan, 81362

Actively Recruiting

296

Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 1331)

Kaohsiung City, Taiwan, 83301

Actively Recruiting

297

China Medical University Hospital-Department of Urology ( Site 1335)

Taichung, Taiwan, 40447

Actively Recruiting

298

Taichung Veterans General Hospital ( Site 1338)

Taichung, Taiwan, 40705

Actively Recruiting

299

Taipei Veterans General Hospital ( Site 1332)

Taipei, Taiwan, 112

Actively Recruiting

300

Chang Gung Medical Foundation-Linkou Branch-Urology ( Site 1334)

Taoyuan, Taiwan, 333

Actively Recruiting

301

Chulalongkorn University ( Site 1355)

Bangkok, Bangkok, Thailand, 10330

Actively Recruiting

302

Faculty of Medicine Siriraj Hospital ( Site 1356)

Bangkok, Bangkok, Thailand, 10700

Actively Recruiting

303

Faculty of Medicine - Khon Kaen University ( Site 1351)

Muang, Changwat Khon Kaen, Thailand, 40002

Active, Not Recruiting

304

Songklanagarind hospital ( Site 1352)

Hat Yai, Changwat Songkhla, Thailand, 90110

Actively Recruiting

305

Maharaj Nakorn Chiang Mai Hospital ( Site 1353)

Muang, Chiang Mai, Thailand, 50200

Actively Recruiting

306

Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1379)

Adana, Turkey (Türkiye), 01250

Actively Recruiting

307

Hacettepe Universite Hastaneleri-oncology hospital ( Site 1376)

Ankara, Turkey (Türkiye), 06230

Actively Recruiting

308

Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1377)

Ankara, Turkey (Türkiye), 06800

Actively Recruiting

309

Koc Universitesi Hastanesi ( Site 1384)

Istanbul, Turkey (Türkiye), 34010

Actively Recruiting

310

T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Baki-Istanbul Bakirkoy Sadi Konuk Training ( Site 1381)

Istanbul, Turkey (Türkiye), 34147

Actively Recruiting

311

Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1383)

Istanbul, Turkey (Türkiye), 34668

Actively Recruiting

312

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1378)

Istanbul, Turkey (Türkiye), 34722

Actively Recruiting

313

Ege Universitesi Hastanesi-Medical Oncology ( Site 1380)

Izmir, Turkey (Türkiye), 35100

Actively Recruiting

314

Samsun Medical Park Hastanesi-medical oncology ( Site 1382)

Samsun, Turkey (Türkiye), 55200

Actively Recruiting

315

Addenbrooke's Hospital ( Site 1426)

Cambridge, Cambridgeshire, United Kingdom, CB2 2QQ

Actively Recruiting

316

Royal Derby Hospital ( Site 1431)

Derby, Derbyshire, United Kingdom, DE22 3NE

Actively Recruiting

317

Torbay Hospital ( Site 1429)

Torquay, Devon, United Kingdom, TQ2 7AA

Actively Recruiting

318

Mount Vernon Cancer Centre ( Site 1440)

Northwood, England, United Kingdom, HA6 2RN

Actively Recruiting

319

The Royal Cornwall Hospital ( Site 1430)

Truro, England, United Kingdom, TR1 3LJ

Actively Recruiting

320

The Beatson West of Scotland Cancer Centre ( Site 1428)

Glasgow, Glasgow City, United Kingdom, G12 0YN

Actively Recruiting

321

Charing Cross Hospital-Oncology Research ( Site 1434)

London, Hammersmith and Fulham, United Kingdom, W6 8RF

Actively Recruiting

322

University College London Hospital ( Site 1437)

London, London, City of, United Kingdom, NW1 2PG

Actively Recruiting

323

Guy's & St Thomas' NHS Foundation Trust-Oncology & Haematology Clinical Trials ( Site 1435)

London, London, City of, United Kingdom, SE1 9RT

Active, Not Recruiting

324

St. George's Hospital-Oncology ( Site 1441)

London, London, City of, United Kingdom, SW17 0QT

Completed

325

GenesisCare - Oxford ( Site 1442)

Oxford, Oxfordshire, United Kingdom, OX4 6LB

Active, Not Recruiting

326

GenesisCare - Windsor ( Site 1443)

Windsor, Windsor And Maidenhead, United Kingdom, SL4 3HD

Active, Not Recruiting

327

The Christie NHS Foundation Trust ( Site 1436)

Manchester, United Kingdom, m20 4bx

Actively Recruiting

Loading map...

Research Team

T

Toll Free Number

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Usefulness of Tumor Heterogeneity Assessment in Patients Wit...

Prostatic Neoplasms

Actively Recruiting

1 location

A Phase 3 Open-label Study of Ifinatamab Deruxtecan Versus D...

Prostate Cancer

Actively Recruiting

285 locations

A Multicenter, Open-Label Phase II Study to Evaluate the Saf...

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Actively Recruiting

24 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Steroidogenesis inhibitor opevesostat (MK-5684) for metastatic castration-resistant prostate cancer: OMAHA-003 and OMAHA-004 trial designs.

Evan Y Yu, Christian Gratzke, Mauricio Burotto...

https://pubmed.ncbi.nlm.nih.gov/41732008